Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-19-001517
Filing Date
2019-01-24
Accepted
2019-01-24 17:15:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424(B)(5) s002635x1_424b5.htm 424B5 524210
2 logo_rexahn1.jpg GRAPHIC 38835
  Complete submission text file 0001140361-19-001517.txt   578814
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218285 | Film No.: 19540612
SIC: 2834 Pharmaceutical Preparations